• (PLX AI) – Ambu Q4 EBIT DKK 4 million.
  • • Outlook FY organic growth 15-19%
  • • Outlook FY EBIT margin 7-9%
  • • The organic growth will be driven by Visualization’s most recent product launches, while Anaesthesia and PMD are expected to be positively impacted by a gradually normalising demand, company says
  • • Says organic revenue for Q1 2021/22 is expected to be flat over Q1 2020/21, as we face a high comparable driven by last year’s NHS safety stock orders
  • • Says expect a negative impact from raw material inflation and continued high supply chain costs
  • • For Q1 2021/22, says EBIT margin is expected to be low and gradually improve as we build financial scale

Quelle: PLX AI